Try GOLD - Free
AYURVEDIC HOSPITAL CARE: WHY INSURERS PUSH BACK—AND HOW TO WIN CLAIMS
Mint Chennai
|November 20, 2025
Over the past few years, a friend has undergone Ayurvedic treatment for fluctuating blood pressure at a Kerala hospital. The insurer had routinely covered a week of hospitalization, but this time rejected the claim, arguing the annual treatment appeared more like rest than medical necessity. Ayurvedic claims are becoming harder to get approved.
Ayurveda remains popular, especially for chronic, low-severity conditions such as hypertension, high cholesterol and arthritis. Severity often determines the treatment path—someone with mildly elevated creatinine may opt for Ayurveda alone or as a supplement, but higher levels may require dialysis.
The growing use of Ayurveda, especially for chronic low-severity illnesses, creates a unique challenge for insurers. Allopathic treatment for such conditions usually happens on an outpatient (OPD) basis, so insurers don’t pay for it. But Ayurvedic treatment for the same conditions often requires hospitalization— and insurers do pay for that. Such hospitalization may be repeated annually for long-term benefits. So, from an insurer's perspective, Ayurvedic hospitalization results in additional cost that they would not otherwise have borne.
This story is from the November 20, 2025 edition of Mint Chennai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Chennai
Mint Chennai
Is America’s economy turning into a casino? Both yes and no
Americans are taking too many bad risks and too few good ones
3 mins
November 20, 2025
Mint Chennai
Global reset done, TVS supply chain unit eyes margin boost
TVS Supply Chain Solutions (SCS), whose wafer-thin margins and weak post-IPO performance have dampened investor sentiment since its 2023 debut, is looking to reset expectations after a major overhaul of its overseas operations.
2 mins
November 20, 2025
Mint Chennai
A fresh perspective on abstraction in art
A new exhibition in Mumbai showcases different approaches to abstraction by artists like Zarina, Seher Shah and Mehlli Gobhai
3 mins
November 20, 2025
Mint Chennai
A Gustav Klimt portrait shatters art records
Portrait of Elisabeth Lederer was sold at Sotheby's for $236.4 million
2 mins
November 20, 2025
Mint Chennai
Exide's dual bet: Can lithium-ion offset a weakening core?
Exide Industries Ltd is struggling to fuel its core lead-acid business while simultaneously turning its capex-heavy lithium-ion venture into a viable second growth engine.
1 mins
November 20, 2025
Mint Chennai
The crypto trades that amplified gains are now turbocharging losses
The rally in crypto prices this year was boosted by a large heap of debt, with traders using leverage to amplify their gains.
3 mins
November 20, 2025
Mint Chennai
Sebi mulls easing FPI trade settlement
The move would reduce costs for FPIs, says Sebi chairperson Tuhin Kanta Pandey.
1 min
November 20, 2025
Mint Chennai
Samsung India logs double-digit growth
Samsung India Electronics said it has clocked a double digit growth in its revenue from operations of over 11% to ₹1.11 trillion in the financial year ended March 2025.
1 min
November 20, 2025
Mint Chennai
BSNL dials vendors for a fix as regulator flags weak signal
State-owned Bharat Sanchar Nigam Ltd (BSNL) has flagged weak transmission signals at thousands of its new 4G towers—an issue behind call drops and slower data speeds—at a time when the operator is attempting a long-awaited turnaround backed by the government's successive revival packages.
1 mins
November 20, 2025
Mint Chennai
RP-Sanjiv Goenka enters luxe fashion with FSP stake buy
PSG Ventures Ltd, part of the RP-Sanjiv Goenka Group, on Wednesday approved the acquisition of a 40% stake in FSP Design Pvt. Ltd, the company behind the luxury fashion label Falguni Shane Peacock (FSP), is marking its formal entry into India’s luxury apparel and lifestyle market.
1 mins
November 20, 2025
Listen
Translate
Change font size

